Steroids for severe breathing problems in the ICU
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study tests whether a corticosteroid (a type of anti-inflammatory medicine) can help people with severe breathing problems or serious infections who have a specific 'hyperinflammatory' pattern. If you are in the ICU on a ventilator, this trial may be an option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a severe breathing problem (ARDS) or a serious infection that affects your whole body (sepsis).
- You are on a breathing machine (ventilator) in the intensive care unit (ICU).
- Your doctor can start the study medicine within 3 days (72 hours) of your breathing problem starting.
- You do not have certain conditions like recent heart surgery, long-term steroid use, or a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if adding a type of steroid (glucocorticoid) to standard treatment helps people on a breathing machine recover from severe lung failure (ARDS). It compares different doses to see which works best.
This trial studies a quick set of tests to figure out whether a person with severe infection (sepsis) will respond to corticosteroids like hydrocortisone. The goal is to guide treatment sooner and avoid ineffective care.
This trial tests if giving steroids early, based on your immune system, can help treat severe pneumonia that needs ICU care. It aims to reduce inflammation and improve recovery.
This study tests whether giving steroids (a type of anti-inflammatory medicine) to adults hospitalized with severe respiratory infections can help them recover faster. If you have a serious lung infection and low oxygen levels, this trial may be an option for you.
This trial tests whether the steroid dexamethasone can help people with sepsis who develop acute respiratory distress syndrome (ARDS), a severe lung injury. If you have an infection and need breathing support, this study may help find a better treatment.
This trial tests if anti-inflammatory drugs tailored to specific germs can help patients in the ICU with severe community-acquired pneumonia recover faster. You may be eligible if you've been in the ICU less than 48 hours and meet certain diagnostic criteria.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.